Literature DB >> 17475864

Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent.

Elizabeth A Ramsburg1, Jean M Publicover, Dagan Coppock, John K Rose.   

Abstract

CD4 Th cells play critical roles in stimulating Ab production and in generating primary or maintaining memory CTL. The requirement for CD4 help in generating and maintaining CTL responses has been reported to vary depending on the vector or method used for immunization. In this study, we examined the requirement for CD4 T cell help in generating and maintaining CTL responses to an experimental AIDS vaccine vector based on live recombinant vesicular stomatitis virus (VSV) expressing HIV Env protein. We found that primary CD8 T cell responses and short-term memory to HIV Env and VSV nucleocapsid (VSV N) proteins were largely intact in CD4 T cell-deficient mice. These responses were efficiently recalled at 30 days postinfection by boosting with vaccinia recombinants expressing HIV Env or VSV N. However, by 60 days postinfection, the memory/recall response to VSV N was lost in CD4-deficient mice, while the recall response HIV Env was partially maintained in the same animals for at least 90 days. This result indicates that there are epitope-specific requirements for CD4 help in the maintenance of memory CD8 T cell responses. Our results also suggest that choice of epitopes might be critical in an AIDS vaccine designed to protect against disease in the context of reduced or declining CD4 T cell help.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475864     DOI: 10.4049/jimmunol.178.10.6350

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.

Authors:  Melissa A Cobleigh; Linda Buonocore; Susan L Uprichard; John K Rose; Michael D Robek
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

3.  Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.

Authors:  Catherine Riou; Vitaly V Ganusov; Suzanne Campion; Mandla Mlotshwa; Michael K P Liu; Victoria E Whale; Nilu Goonetilleke; Persephone Borrow; Guido Ferrari; Michael R Betts; Barton F Haynes; Andrew J McMichael; Clive M Gray
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

4.  CD40 is required for protective immunity against liver stage Plasmodium infection.

Authors:  Sara A Murray; Isaac Mohar; Jessica L Miller; Katherine J Brempelis; Ashley M Vaughan; Stefan H I Kappe; Ian N Crispe
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

5.  Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.

Authors:  Zaza M Ndhlovu; Alicja Piechocka-Trocha; Seanna Vine; Ashley McMullen; Kegakilwe C Koofhethile; Phillip J R Goulder; Thumbi Ndung'u; Dan H Barouch; Bruce D Walker
Journal:  J Immunol       Date:  2011-05-16       Impact factor: 5.422

6.  The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice.

Authors:  Dongqing Gu; Wei Chen; Youjun Mi; Xueli Gong; Tao Luo; Lang Bao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

7.  H5N1 strain-specific hemagglutinin CD4+ T cell epitopes restricted by HLA DR4.

Authors:  Junbao Yang; John A Gebe; Laurie Huston; Eddie James; Venus Tan; Betty B Yue; Gerald T Nepom; William W Kwok
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

8.  Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Authors:  Christopher C Kemball; Eva Szomolanyi-Tsuda; Aron E Lukacher
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.

Authors:  Maryam Ahmed; Tracie R Marino; Shelby Puckett; Nancy D Kock; Douglas S Lyles
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

10.  Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.

Authors:  Ryann C Guayasamin; Tracy D Reynolds; Xin Wei; Mai Fujiwara; Michael D Robek
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.